BOTHELL, Wash.--(BUSINESS WIRE)--Acucela Inc., a clinical-stage biotechnology company focused on developing therapies for blinding eye diseases, announced today that Ryo Kubota, M.D., Ph.D., Acucela’s chief executive officer, will present a company update at the Rodman & Renshaw 10th Annual Healthcare Conference. The presentation is scheduled for 10:20 a.m. EST on Wednesday, November 12, 2008 at the New York Palace Hotel in New York City.
